XML 45 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Equity | 9 Months Ended
--- | ---
Sep. 30, 2020
Equity [Abstract] |
EQUITY | EQUITY Equity Transactions with Noncontrolling Interests AES Gener — In September 2020, AES Gener completed the sale of a portion of its stake in Cochrane. The transaction included the issuance of preferred shares and the sale of 5% of its stake in the subsidiary for $113 million, which decreased the Company’s economic interest in Cochrane to 38%. As the Company maintained control after the sale, Cochrane continues to be consolidated by the Company within the South America SBU reportable segment. AES Tietê — In August 2020, AES Holdings Brasil Ltda. completed the acquisition of an additional 18.5% ownership in AES Tietê for $240 million which increased the Company’s economic interest in AES Tietê to 42.9%. This transaction resulted in a $202 million decrease in Parent Company Stockholders’ Equity due to a decrease in additional paid-in-capital of $88 million and the reclassification of accumulated other comprehensive losses from NCI to AOCL of $114 million. As the Company maintained control after the sale, AES Tietê continues to be consolidated by the Company within the South America SBU reportable segment. Accumulated Other Comprehensive Loss — The following table summarizes the changes in AOCL by component, net of tax and NCI, for the nine months ended September 30, 2020 (in millions):
| Foreign currency translation adjustment, net |  | Unrealized derivative gains (losses), net |  | Unfunded pension obligations, net |  | Total
Balance at the beginning of the period | $ | (1,721) |  |  | $ | (470) |  |  | $ | (38) |  |  | $ | (2,229) |
Other comprehensive loss before reclassifications | (43) |  |  | (388) |  |  | (1) |  |  | (432) |
Amount reclassified to earnings | 78 |  |  | 69 |  |  | 1 |  |  | 148 |
Other comprehensive income (loss) | 35 |  |  | (319) |  |  | — |  |  | (284) |
Reclassification from NCI due to share repurchases | (109) |  |  | (2) |  |  | (4) |  |  | (115) |
Balance at the end of the period | $ | (1,795) |  |  | $ | (791) |  |  | $ | (42) |  |  | $ | (2,628) |
Reclassifications out of AOCL are presented in the following table. Amounts for the periods indicated are in millions and those in parentheses indicate debits to the Condensed Consolidated Statements of Operations:
AOCL Components |  | Affected Line Item in the Condensed Consolidated Statements of Operations |  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2020 |  | 2019 |  | 2020 |  | 2019
Foreign currency translation adjustment, net |  |
|  | Gain (loss) on disposal and sale of business interests |  | $ | (80) |  |  | $ | — |  |  | $ | (78) |  |  | $ | (23) |
|  | Net income (loss) attributable to The AES Corporation |  | $ | (80) |  |  | $ | — |  |  | $ | (78) |  |  | $ | (23) |
Derivative gains (losses), net |  |  |  |  |  |  |  |
|  | Non-regulated revenue |  | $ | — |  |  | $ | — |  |  | $ | (1) |  |  | $ | — |
|  | Non-regulated cost of sales |  | (1) |  |  | (1) |  |  | — |  |  | (11) |
|  | Interest expense |  | (42) |  |  | (8) |  |  | (89) |  |  | (23) |
|  | Gain (loss) on disposal and sale of business interests |  | — |  |  | — |  |  | — |  |  | 1 |
|  | Foreign currency transaction gains (losses) |  | 9 |  |  | (14) |  |  | (14) |  |  | (11) |
|  | Income (loss) from continuing operations before taxes and equity in earnings of affiliates |  | (34) |  |  | (23) |  |  | (104) |  |  | (44) |
|  | Income tax benefit (expense) |  | 10 |  |  | 6 |  |  | 24 |  |  | 10 |
|  | Net equity in earnings (losses) of affiliates |  | (3) |  |  | — |  |  | (4) |  |  | (2) |
|  | Income (loss) from continuing operations |  | (27) |  |  | (17) |  |  | (84) |  |  | (36) |
|  | Less: Net loss (income) attributable to noncontrolling interests and redeemable stock of subsidiaries |  | 26 |  |  | 2 |  |  | 15 |  |  | 3 |
|  | Net income (loss) attributable to The AES Corporation |  | $ | (1) |  |  | $ | (15) |  |  | $ | (69) |  |  | $ | (33) |
Amortization of defined benefit pension actuarial loss, net |  |  |  |  |  |  |  |
|  | Non-regulated cost of sales |  | $ | (1) |  |  | $ | — |  |  | $ | (1) |  |  | $ | — |
|  | Other expense |  | — |  |  | — |  |  | (1) |  |  | (1) |
|  | Gain (loss) on disposal and sale of business interests |  | — |  |  | — |  |  | — |  |  | (26) |
|  | Income (loss) from continuing operations before taxes and equity in earnings of affiliates |  | (1) |  |  | — |  |  | (2) |  |  | (27) |
|  | Income tax benefit (expense) |  | — |  |  | — |  |  | 1 |  |  | — |
|  | Net income (loss) attributable to The AES Corporation |  | $ | (1) |  |  | $ | — |  |  | $ | (1) |  |  | $ | (27) |
Total reclassifications for the period, net of income tax and noncontrolling interests |  | $ | (82) |  |  | $ | (15) |  |  | $ | (148) |  |  | $ | (83) |
Common Stock Dividends — The Parent Company paid dividends of $0.1433 per outstanding share to its common stockholders during the first, second and third quarters of 2020 for dividends declared in December 2019, February 2020 and July 2020, respectively. On October 9, 2020, the Board of Directors declared a quarterly common stock dividend of $0.1433 per share payable on November 16, 2020, to shareholders of record at the close of business on October 30, 2020.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration